{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T15:56:25Z","timestamp":1792338985538,"version":"4.4.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","ackdjournal.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Chronic Kidney Disease"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1053\/j.ackd.2016.02.002","type":"journal-article","created":{"date-parts":[[2016,6,18]],"date-time":"2016-06-18T14:29:45Z","timestamp":1466260185000},"page":"255-261","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hypertension Management in Transition: From CKD to ESRD"],"prefix":"10.1053","volume":"23","author":[{"given":"Aziz","family":"Valika","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo J.","family":"Peixoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1053\/j.ackd.2016.02.002_bib1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.amjmed.2007.11.025","article-title":"Hypertension awareness, treatment, and control in chronic kidney disease","volume":"121","author":"Sarafidis","year":"2008","journal-title":"Am J Med"},{"issue":"7","key":"10.1053\/j.ackd.2016.02.002_bib2","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJMoa1000552","article-title":"A randomized, controlled trial of early versus late initiation of dialysis","volume":"363","author":"Cooper","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1053\/j.ackd.2016.02.002_bib3","series-title":"U.S. Renal Data System, USRDS 2014 Annual Data Report: Atlas of End-Stage Renal Disease in the United States","year":"2014"},{"issue":"11","key":"10.1053\/j.ackd.2016.02.002_bib4","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1038\/sj.ki.5001934","article-title":"The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease","volume":"70","author":"Charytan","year":"2006","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ackd.2016.02.002_bib5","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1053\/j.ackd.2014.02.012","article-title":"Research in the CKD clinic: highs and lows","volume":"21","author":"Decker","year":"2014","journal-title":"Adv Chronic Kidney Dis"},{"issue":"1","key":"10.1053\/j.ackd.2016.02.002_bib6","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/HYPERTENSIONAHA.108.115154","article-title":"Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease","volume":"53","author":"Pogue","year":"2009","journal-title":"Hypertension"},{"issue":"5","key":"10.1053\/j.ackd.2016.02.002_bib7","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1053\/j.ajkd.2014.06.014","article-title":"Assessment of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study","volume":"64","author":"Minutolo","year":"2014","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"10.1053\/j.ackd.2016.02.002_bib8","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.2215\/CJN.11301111","article-title":"Relationship between ambulatory BP and clinical outcomes in patients with hypertensive CKD","volume":"7","author":"Gabbai","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1053\/j.ackd.2016.02.002_bib9","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2215\/CJN.05391008","article-title":"Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis","volume":"4","author":"Bangash","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.ackd.2016.02.002_bib10","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.2169\/internalmedicine.44.1239","article-title":"Morning blood pressure predicts hypertensive organ damage in patients with renal diseases: effect of intensive antihypertensive therapy in patients with diabetic nephropathy","volume":"44","author":"Kuriyama","year":"2005","journal-title":"Intern Med"},{"issue":"6","key":"10.1053\/j.ackd.2016.02.002_bib11","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.2215\/CJN.02250507","article-title":"Home blood pressures are of greater prognostic value than hemodialysis unit recordings","volume":"2","author":"Alborzi","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.ackd.2016.02.002_bib12","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1093\/ndt\/gfp332","article-title":"Home blood pressure monitoring in blood pressure control among haemodialysis patients: an open randomized clinical trial","volume":"24","author":"da Silva","year":"2009","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ackd.2016.02.002_bib13","first-page":"CD005182","article-title":"Interventions used to improve control of blood pressure in patients with hypertension","author":"Glynn","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"10.1053\/j.ackd.2016.02.002_bib14","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1038\/jhh.2010.54","article-title":"European Society of Hypertension practice guidelines for home blood pressure monitoring","volume":"24","author":"Parati","year":"2010","journal-title":"J Hum Hypertens"},{"issue":"1","key":"10.1053\/j.ackd.2016.02.002_bib15","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/HYPERTENSIONAHA.111.00100","article-title":"Outcome-driven thresholds for home blood pressure measurement: international database of home blood pressure in relation to cardiovascular outcome","volume":"61","author":"Niiranen","year":"2013","journal-title":"Hypertension"},{"issue":"7","key":"10.1053\/j.ackd.2016.02.002_bib16","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1681\/ASN.2004090763","article-title":"Impact of achieved blood pressure on cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial","volume":"16","author":"Berl","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2016.02.002_bib17","first-page":"342","article-title":"The effect of a lower target blood pressure on the progression of kidney disease: long-term follow-up of the modification of diet in renal disease study","volume":"142","author":"Sarnak","year":"2005","journal-title":"Ann\u00a0Intern Med"},{"issue":"10","key":"10.1053\/j.ackd.2016.02.002_bib18","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1056\/NEJMoa0910975","article-title":"Intensive blood-pressure control in hypertensive chronic kidney disease","volume":"363","author":"Appel","year":"2010","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1053\/j.ackd.2016.02.002_bib19","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"issue":"5","key":"10.1053\/j.ackd.2016.02.002_bib20","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"28","key":"10.1053\/j.ackd.2016.02.002_bib21","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"34","author":"Mancia","year":"2013","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1053\/j.ackd.2016.02.002_bib22","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/MNH.0b013e32833f0d82","article-title":"Blood pressure management in hemodialysis: what have we learned?","volume":"19","author":"Peixoto","year":"2010","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"4","key":"10.1053\/j.ackd.2016.02.002_bib23","doi-asserted-by":"crossref","first-page":"233","DOI":"10.7326\/0003-4819-159-4-201308200-00004","article-title":"Blood pressure and mortality in U.S. veterans with chronic kidney disease: a cohort study","volume":"159","author":"Kovesdy","year":"2013","journal-title":"Ann Intern Med"},{"issue":"5","key":"10.1053\/j.ackd.2016.02.002_bib24","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ki.2014.376","article-title":"Association between strict blood pressure control during chronic kidney disease and lower mortality after onset of end-stage renal disease","volume":"87","author":"Ku","year":"2015","journal-title":"Kidney Int"},{"issue":"1","key":"10.1053\/j.ackd.2016.02.002_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1523-1755.2005.00050.x","article-title":"Hypertension and survival in chronic hemodialysis patients\u2014past lessons and future opportunities","volume":"67","author":"Agarwal","year":"2005","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ackd.2016.02.002_bib26","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1111\/j.1523-1755.2000.00388.x","article-title":"Importance of blood pressure control in hemodialysis patient survival","volume":"58","author":"Mazzuchi","year":"2000","journal-title":"Kidney Int"},{"issue":"2","key":"10.1053\/j.ackd.2016.02.002_bib27","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1681\/ASN.2004110921","article-title":"Changing relationship of blood pressure with mortality over time among hemodialysis patients","volume":"17","author":"Stidley","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2016.02.002_bib28","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1161\/HYPERTENSIONAHA.108.128116","article-title":"Cardiovascular protection with antihypertensive drugs in dialysis patients: systematic review and meta-analysis","volume":"53","author":"Agarwal","year":"2009","journal-title":"Hypertension"},{"issue":"9668","key":"10.1053\/j.ackd.2016.02.002_bib29","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0140-6736(09)60212-9","article-title":"Effect of lowering blood pressure on cardiovascular events and mortality in patients on dialysis: a systematic review and meta-analysis of randomised controlled trials","volume":"373","author":"Heerspink","year":"2009","journal-title":"Lancet"},{"key":"10.1053\/j.ackd.2016.02.002_bib30","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/0002-9343(61)90035-3","article-title":"The role of the kidney in human hypertension. I. Failure of hypertension to develop in the renoprival subject","volume":"31","author":"Merrill","year":"1961","journal-title":"Am J Med"},{"key":"10.1053\/j.ackd.2016.02.002_bib31","first-page":"328","article-title":"Mechanisms of hypertension in renoprival man","volume":"90","author":"Merrill","year":"1964","journal-title":"Can Med Assoc J"},{"key":"10.1053\/j.ackd.2016.02.002_bib32","doi-asserted-by":"crossref","first-page":"f1325","DOI":"10.1136\/bmj.f1325","article-title":"Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials","volume":"346","author":"He","year":"2013","journal-title":"BMJ"},{"issue":"3","key":"10.1053\/j.ackd.2016.02.002_bib33","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1161\/HYPERTENSIONAHA.109.131235","article-title":"Effects of dietary sodium reduction on blood pressure in subjects with resistant hypertension: results from a randomized trial","volume":"54","author":"Pimenta","year":"2009","journal-title":"Hypertension"},{"key":"10.1053\/j.ackd.2016.02.002_bib34","doi-asserted-by":"crossref","first-page":"d4366","DOI":"10.1136\/bmj.d4366","article-title":"Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial","volume":"343","author":"Slagman","year":"2011","journal-title":"BMJ"},{"issue":"6","key":"10.1053\/j.ackd.2016.02.002_bib35","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1093\/ndt\/13.6.1489","article-title":"Regression of left ventricular hypertrophy in haemodialysis patients by ultrafiltration and reduced salt intake without antihypertensive drugs","volume":"13","author":"Ozkahya","year":"1998","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1053\/j.ackd.2016.02.002_bib36","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/ki.2014.207","article-title":"The role of bioimpedance and biomarkers in helping to aid clinical decision-making of volume assessments in dialysis patients","volume":"86","author":"Davies","year":"2014","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ackd.2016.02.002_bib37","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1159\/000369218","article-title":"Routine bioimpedance-derived volume assessment for all hypertensives: a new paradigm","volume":"40","author":"Covic","year":"2014","journal-title":"Am J Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2016.02.002_bib38","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/01.HYP.0000016176.16042.2F","article-title":"Resistant hypertension: comparing hemodynamic management to specialist care","volume":"39","author":"Taler","year":"2002","journal-title":"Hypertension"},{"issue":"3","key":"10.1053\/j.ackd.2016.02.002_bib39","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ki.2013.336","article-title":"Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease","volume":"85","author":"Hung","year":"2014","journal-title":"Kidney Int"},{"issue":"5","key":"10.1053\/j.ackd.2016.02.002_bib40","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1046\/j.1523-1755.2003.00273.x","article-title":"Role of excess volume in the pathophysiology of hypertension in chronic kidney disease","volume":"64","author":"Vasavada","year":"2003","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ackd.2016.02.002_bib41","first-page":"525","article-title":"Thiazide diuretics in chronic kidney disease","volume":"17","author":"Sinha","year":"2015","journal-title":"Curr Hypertens Rep"},{"issue":"19","key":"10.1053\/j.ackd.2016.02.002_bib42","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/j.jacc.2010.06.034","article-title":"Combination of loop diuretics with thiazide-type diuretics in heart failure","volume":"56","author":"Jentzer","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1053\/j.ackd.2016.02.002_bib43","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1038\/ki.1994.298","article-title":"Coadministration of thiazides increases the efficacy of loop diuretics even in patients with advanced renal failure","volume":"46","author":"Fliser","year":"1994","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ackd.2016.02.002_bib44","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00005344-199509000-00008","article-title":"Diuretic effectiveness of hydrochlorothiazide and furosemide alone and in combination in chronic renal failure","volume":"26","author":"Knauf","year":"1995","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"issue":"2","key":"10.1053\/j.ackd.2016.02.002_bib45","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1093\/ndt\/gfh650","article-title":"A randomized trial of furosemide vs hydrochlorothiazide in patients with chronic renal failure and hypertension","volume":"20","author":"Dussol","year":"2005","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1053\/j.ackd.2016.02.002_bib46","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1751-7176.2011.00564.x","article-title":"A pilot study comparing furosemide and hydrochlorothiazide in patients with hypertension and stage 4 or 5 chronic kidney disease","volume":"14","author":"Dussol","year":"2012","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"2","key":"10.1053\/j.ackd.2016.02.002_bib47","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1159\/000358603","article-title":"Chlorthalidone for poorly controlled hypertension in chronic kidney disease: an interventional pilot study","volume":"39","author":"Agarwal","year":"2014","journal-title":"Am J Nephrol"},{"issue":"2","key":"10.1053\/j.ackd.2016.02.002_bib48","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1056\/NEJMoa053107","article-title":"Efficacy and safety of benazepril for advanced chronic renal insufficiency","volume":"354","author":"Hou","year":"2006","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1053\/j.ackd.2016.02.002_bib49","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.2215\/CJN.04300709","article-title":"Strategies for improving long-term survival in peritoneal dialysis patients","volume":"5","author":"Kendrick","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"10.1053\/j.ackd.2016.02.002_bib50","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1177\/089686080902900514","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in peritoneal dialysis: systematic review and meta-analysis of randomized controlled trials","volume":"29","author":"Akbari","year":"2009","journal-title":"Perit Dial Int"},{"issue":"11","key":"10.1053\/j.ackd.2016.02.002_bib51","doi-asserted-by":"crossref","first-page":"3704","DOI":"10.1093\/ndt\/gfn321","article-title":"Use of ACE inhibitors or angiotensin receptor blockers and survival in patients on peritoneal dialysis","volume":"23","author":"Fang","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"21","key":"10.1053\/j.ackd.2016.02.002_bib52","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.jacc.2010.03.105","article-title":"Effects of telmisartan added to angiotensin-converting enzyme inhibitors on mortality and morbidity in hemodialysis patients with chronic heart failure a double-blind, placebo-controlled trial","volume":"56","author":"Cice","year":"2010","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1053\/j.ackd.2016.02.002_bib53","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1053\/j.ajkd.2008.04.031","article-title":"Effect of angiotensin receptor blockers on cardiovascular events in patients undergoing hemodialysis: an open-label randomized controlled trial","volume":"52","author":"Suzuki","year":"2008","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"10.1053\/j.ackd.2016.02.002_bib54","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1093\/ndt\/gfl293","article-title":"Candesartan, an angiotensin II type-1 receptor blocker, reduces cardiovascular events in patients on chronic haemodialysis\u2014a randomized study","volume":"21","author":"Takahashi","year":"2006","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"10.1053\/j.ackd.2016.02.002_bib55","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1093\/ndt\/gfs590","article-title":"Effects of angiotensin receptor blockade (ARB) on mortality and cardiovascular outcomes in patients with long-term haemodialysis: a randomized controlled trial","volume":"28","author":"Iseki","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1053\/j.ackd.2016.02.002_bib56","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/sj.ki.5001657","article-title":"Prevention of cardiovascular events in end-stage renal disease: results of a randomized trial of fosinopril and implications for future studies","volume":"70","author":"Zannad","year":"2006","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ackd.2016.02.002_bib57","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/ndt\/gft515","article-title":"Hypertension in hemodialysis patients treated with atenolol or lisinopril: a randomized controlled trial","volume":"29","author":"Agarwal","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1053\/j.ackd.2016.02.002_bib58","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0735-1097(03)00241-9","article-title":"Carvedilol increases two-year survivalin dialysis patients with dilated cardiomyopathy: a prospective, placebo-controlled trial","volume":"41","author":"Cice","year":"2003","journal-title":"J Am Coll Cardiol"},{"issue":"18","key":"10.1053\/j.ackd.2016.02.002_bib59","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1001\/jama.292.18.2227","article-title":"Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and underhypertension: a randomized controlled trial","volume":"292","author":"Bakris","year":"2004","journal-title":"JAMA"},{"issue":"4","key":"10.1053\/j.ackd.2016.02.002_bib60","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1046\/j.1523-1755.1999.00359.x","article-title":"Supervised atenolol therapy in the management of hemodialysis hypertension","volume":"55","author":"Agarwal","year":"1999","journal-title":"Kidney Int"},{"issue":"4","key":"10.1053\/j.ackd.2016.02.002_bib61","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1681\/ASN.2014040324","article-title":"Beta-blocker dialyzability and mortality in older patients receiving hemodialysis","volume":"26","author":"Weir","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1053\/j.ackd.2016.02.002_bib62","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1053\/j.ackd.2016.02.002_bib63","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1046\/j.1523-1755.1998.00083.x","article-title":"Effects of an ACE inhibitor\/calcium antagonist combination on proteinuria in diabetic nephropathy","volume":"54","author":"Bakris","year":"1998","journal-title":"Kidney Int"},{"issue":"3","key":"10.1053\/j.ackd.2016.02.002_bib64","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1523-1755.1998.00055.x","article-title":"Differential effects of calcium channel blockers on size selectivity of proteinuria in diabetic glomerulopathy","volume":"54","author":"Smith","year":"1998","journal-title":"Kidney Int"},{"issue":"9721","key":"10.1053\/j.ackd.2016.02.002_bib65","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1016\/S0140-6736(09)62100-0","article-title":"Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial","volume":"375","author":"Bakris","year":"2010","journal-title":"Lancet"},{"issue":"11","key":"10.1053\/j.ackd.2016.02.002_bib66","doi-asserted-by":"crossref","first-page":"3605","DOI":"10.1093\/ndt\/gfn304","article-title":"Effect of amlodipine on cardiovascular events in hypertensive haemodialysis patients","volume":"23","author":"Tepel","year":"2008","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1053\/j.ackd.2016.02.002_bib67","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archinternmed.2009.132","article-title":"The frequency of hyperkalemia and its significance in chronic kidney disease","volume":"169","author":"Einhorn","year":"2009","journal-title":"Arch Intern Med"},{"issue":"2","key":"10.1053\/j.ackd.2016.02.002_bib68","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.ajkd.2007.10.040","article-title":"Change in proteinuria after adding aldosterone blockers to ACE inhibitors or angiotensin receptor blockers in CKD: a systematic review","volume":"51","author":"Bomback","year":"2008","journal-title":"Am\u00a0J\u00a0Kidney Dis"},{"issue":"3","key":"10.1053\/j.ackd.2016.02.002_bib69","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2215\/CJN.04750908","article-title":"Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis","volume":"4","author":"Navaneethan","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"10","key":"10.1053\/j.ackd.2016.02.002_bib70","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.2215\/CJN.01340209","article-title":"Mineralocorticoid receptor blockers and chronic kidney disease","volume":"4","author":"Jain","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"10.1053\/j.ackd.2016.02.002_bib71","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jacc.2013.09.056","article-title":"Spironolactone reduces\u00a0cardiovascular and cerebrovascular morbidity and mortality in hemodialysis patients","volume":"63","author":"Matsumoto","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"6","key":"10.1053\/j.ackd.2016.02.002_bib72","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.169961","article-title":"Addition of spironolactone in patients with resistant arterial hypertension (ASPIRANT): a randomized, double-blind, placebo-controlled trial","volume":"57","author":"Vaclavik","year":"2011","journal-title":"Hypertension"},{"issue":"8","key":"10.1053\/j.ackd.2016.02.002_bib73","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/jhh.2011.60","article-title":"Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease","volume":"26","author":"Pisoni","year":"2012","journal-title":"J Hum Hypertens"},{"issue":"5","key":"10.1053\/j.ackd.2016.02.002_bib74","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1159\/000237742","article-title":"Predictors of hyperkalemia risk following hypertension control with aldosterone blockade","volume":"30","author":"Khosla","year":"2009","journal-title":"Am J\u00a0Nephrol"}],"container-title":["Advances in Chronic Kidney Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559516000215?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1548559516000215?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T14:32:36Z","timestamp":1600785156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1548559516000215"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1548559516000215"],"URL":"https:\/\/doi.org\/10.1053\/j.ackd.2016.02.002","relation":{},"ISSN":["1548-5595"],"issn-type":[{"value":"1548-5595","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypertension Management in Transition: From CKD to ESRD","name":"articletitle","label":"Article Title"},{"value":"Advances in Chronic Kidney Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.ackd.2016.02.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the National Kidney Foundation, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}